Gene · 9113
Papers3,081
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 3,081
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Recent Progress in Cardiovascular Research Involving Single-Cell Omics Approaches. | Front Cardiovasc Med | 2021 | 34977189 | PubTator, text mining | PubMed |
| LncRNA FOXP4-AS1 Promotes the Progression of Esophageal Squamous Cell Carcinoma by Interacting With MLL2/H3K4me3 to Upregulate FOXP4. | Front Oncol | 2021 | 34970490 | PubTator, text mining | PubMed |
| Integrated Analysis of Circular RNA-Associated ceRNA Network Reveals Potential circRNA Biomarkers in Human Breast Cancer. | Comput Math Methods Med | 2021 | 34966440 | PubTator, text mining | PubMed |
| Involvement of the Hippo Pathway in the Development of Diabetes. | Discov Med | 2021 | 34965370 | PubTator, text mining | PubMed |
| Nanoparticle-Based RNAi Therapeutics Targeting Cancer Stem Cells: Update and Prospective. | Pharmaceutics | 2021 | 34959397 | PubTator, text mining | PubMed |
| The Extracellular Matrix in Soft Tissue Sarcomas: Pathobiology and Cellular Signalling. | Front Cell Dev Biol | 2021 | 34957097 | PubTator, text mining | PubMed |
| MiR-29c-3p May Promote the Progression of Alzheimer's Disease through BACE1. | J Healthc Eng | 2021 | 34956559 | PubTator, text mining | PubMed |
| Immune Cell-Derived Extracellular Vesicles - New Strategies in Cancer Immunotherapy. | Front Immunol | 2021 | 34956197 | PubTator, text mining | PubMed |
| The Hippo signaling pathway in leukemia: function, interaction, and carcinogenesis. | Cancer Cell Int | 2021 | 34953494 | PubTator, text mining | PubMed |
| In Situ Cell Signalling of the Hippo-YAP/TAZ Pathway in Reaction to Complex Dynamic Loading in an Intervertebral Disc Organ Culture. | Int J Mol Sci | 2021 | 34948441 | PubTator, text mining | PubMed |
| Autism-Related Transcription Factors Underlying the Sex-Specific Effects of Prenatal Bisphenol A Exposure on Transcriptome-Interactome Profiles in the Offspring Prefrontal Cortex. | Int J Mol Sci | 2021 | 34947998 | PubTator, text mining | PubMed |
| Activation of the Hippo Pathway in Rana sylvatica: Yapping Stops in Response to Anoxia. | Life (Basel) | 2021 | 34947952 | PubTator, text mining | PubMed |
| The World of Pseudogenes: New Diagnostic and Therapeutic Targets in Cancers or Still Mystery Molecules? | Life (Basel) | 2021 | 34947885 | PubTator, text mining | PubMed |
| The Hippo Signaling Pathway in Cancer: A Cell Cycle Perspective. | Cancers (Basel) | 2021 | 34944834 | PubTator, text mining | PubMed |
| YAP/Hippo Pathway and Cancer Immunity: It Takes Two to Tango. | Biomedicines | 2021 | 34944765 | PubTator, text mining | PubMed |
| Somatic Mutational Profile of High-Grade Serous Ovarian Carcinoma and Triple-Negative Breast Carcinoma in Young and Elderly Patients: Similarities and Divergences. | Cells | 2021 | 34944094 | PubTator, text mining | PubMed |
| Drug-Resistant Breast Cancer: Dwelling the Hippo Pathway to Manage the Treatment. | Breast Cancer (Dove Med Press) | 2021 | 34938116 | PubTator, text mining | PubMed |
| CRABP2 involvement in a mechanism of Golgi stress and tumor dry matter in non-small cell lung cancer cells via ER dependent Hippo pathway. | Acta Biochim Pol | 2021 | 34932899 | PubTator, text mining | PubMed |
| MicroRNA miR-4709-3p targets Large Tumor Suppressor Kinase 2 (LATS2) and induces obstructive renal fibrosis through Hippo signaling. | Bioengineered | 2021 | 34931960 | PubTator, text mining | PubMed |
| SEPT6_TRIM33 Gene Fusion and Mutated TP53 Pathway Associate With Unfavorable Prognosis in Patients With B-Cell Lymphomas. | Front Oncol | 2021 | 34926267 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9113/papers?page=50